Comment
. 2008 Apr 20;26(12):2057-8; author reply 2060-1.
doi: 10.1200/JCO.2007.15.5614.
Reaction to American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
- PMID: 18421062
- DOI: 10.1200/JCO.2007.15.5614
Item in Clipboard
Comment
Reaction to American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
J Clin Oncol.
.
No abstract available
Comment on
-
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.J Clin Oncol. 2007 Nov 20;25(33):5287-312. doi: 10.1200/JCO.2007.14.2364. Epub 2007 Oct 22. J Clin Oncol. 2007. PMID: 17954709 Review.
Similar articles
-
Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.Adv Anat Pathol. 2009 Jul;16(4):204-15. doi: 10.1097/PAP.0b013e3181a9d4bf. Adv Anat Pathol. 2009. PMID: 19546609 Review.
-
Commercialized multigene predictors of clinical outcome for breast cancer.Oncologist. 2008 May;13(5):477-93. doi: 10.1634/theoncologist.2007-0248. Oncologist. 2008. PMID: 18515733 Review.
-
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK.Breast Cancer Res Treat. 2006 Nov;100(2):237-8. doi: 10.1007/s10549-006-9253-5. Epub 2006 Jun 14. Breast Cancer Res Treat. 2006. PMID: 16773436 No abstract available.
-
Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices.Clin Lab Med. 2005 Dec;25(4):631-54, v. doi: 10.1016/j.cll.2005.08.003. Clin Lab Med. 2005. PMID: 16308084 Review.
-
[Advantage of using tumor markers in colorectal and breast cancers. Guidelines of the American Society of Clinical Oncology (ASCO)].Bull Cancer. 1997 Jul;84(7):767-8. Bull Cancer. 1997. PMID: 9339206 French. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
